Tumores Triplo Negativos: O que precisamos saber em 2020?
Confira os artigos sobre o tema da nossa Reunião de Outubro
Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with earlystage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Pembrolizumab for Early Triple-Negative Breast Cancer
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
